speb/financial-data huggingface dataset:
CHYM income_statement (annual, 2024-12-31) — Other Gand A: 177229000.00
CHYM income_statement (annual, 2024-12-31) — Other Income Expense: 39465000.00
CHYM cash_flow (annual, 2024-12-31) — Other Non Cash Items: 52453000.00
CHYM balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 31969000.00
CHYM balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 46109000.00
CHYM income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 39465000.00
CHYM income_statement (annual, 2024-12-31) — Other Operating Expenses: 506543000.00
CHYM balance_sheet (annual, 2024-12-31) — Other Properties: 49332000.00
CHYM balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 368889000.00
CHYM balance_sheet (annual, 2024-12-31) — Payables: 35846000.00
CHYM balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 144091000.00
CHYM balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 53344000.00
CHYM balance_sheet (annual, 2024-12-31) — Preferred Stock: 2890121000.00
CHYM balance_sheet (annual, 2024-12-31) — Preferred Stock Equity: 2890121000.00
CHYM balance_sheet (quarterly, 2024-12-31) — Preferred Stock Equity: 2890121000.00
CHYM income_statement (annual, 2024-12-31) — Pretax Income: -22734000.00
CHYM cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 1406000.00
CHYM balance_sheet (annual, 2024-12-31) — Properties: 0.00
CHYM cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 84145000.00
CHYM cash_flow (annual, 2024-12-31) — Purchase Of Business: -13336000.00
CHYM cash_flow (quarterly, 2024-12-31) — Purchase Of Business: -2300000.00
CHYM cash_flow (annual, 2024-12-31) — Purchase Of Investment: -497578000.00
CHYM cash_flow (annual, 2024-12-31) — Purchase Of PPE: -4812000.00
CHYM balance_sheet (annual, 2024-12-31) — Receivables: 315960000.00
CHYM income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 196991000.00
CHYM income_statement (annual, 2024-12-31) — Reconciled Depreciation: 25370000.00
CHYM cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -950000.00
CHYM income_statement (annual, 2024-12-31) — Research And Development: 309575000.00
CHYM balance_sheet (annual, 2024-12-31) — Restricted Cash: 194026000.00
CHYM balance_sheet (annual, 2024-12-31) — Retained Earnings: -2364168000.00
CHYM cash_flow (annual, 2024-12-31) — Sale Of Investment: 701489000.00
CHYM income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 519760000.00
CHYM income_statement (annual, 2024-12-31) — Selling General And Administration: 696989000.00
CHYM balance_sheet (annual, 2024-12-31) — Share Issued: 364421538.00
CHYM cash_flow (annual, 2024-12-31) — Stock Based Compensation: 29845000.00
CHYM balance_sheet (annual, 2024-12-31) — Stockholders Equity: 959521000.00
CHYM balance_sheet (annual, 2024-12-31) — Tangible Book Value: -1930600000.00
CHYM income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CHYM income_statement (annual, 2024-12-31) — Tax Provision: 2610000.00
CHYM income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
CHYM balance_sheet (annual, 2024-12-31) — Total Assets: 1461037000.00
CHYM balance_sheet (annual, 2024-12-31) — Total Capitalization: 959521000.00
CHYM balance_sheet (annual, 2024-12-31) — Total Debt: 96336000.00
CHYM balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 959521000.00
CHYM income_statement (annual, 2024-12-31) — Total Expenses: 1735468000.00
CHYM balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 501516000.00
CHYM balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 174001000.00
CHYM balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 126699000.00
CHYM income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -62199000.00
CHYM balance_sheet (annual, 2024-12-31) — Working Capital: 912219000.00
CHYM income_statement (quarterly, 2025-03-31) — +Operating Expense: 449189000.00
CHYM income_statement (quarterly, 2025-03-31) — +Total Revenue: 518744000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 37614000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 241657000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -52359000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 442829000.00
CHYM cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -1627000.00
CHYM cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 0.00
CHYM income_statement (quarterly, 2025-03-31) — Basic Average Shares: 364421538.00
CHYM income_statement (quarterly, 2025-03-31) — Basic EPS: 0.00
CHYM cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 350000000.00
CHYM cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -4791000.00
CHYM cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -3198000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 91700000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Capital Stock: 2890123000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 318160000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 654627000.00
CHYM cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -126000.00
CHYM cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 6701000.00
CHYM cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -25751000.00
CHYM cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 1768000.00
CHYM cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -73954000.00
CHYM cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -22393000.00
CHYM cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 4151000.00
CHYM cash_flow (quarterly, 2025-03-31) — Change In Payable: 1768000.00
CHYM cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -72186000.00
CHYM cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -8680000.00
CHYM cash_flow (quarterly, 2025-03-31) — Change In Receivables: -26155000.00
CHYM cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -125263000.00
CHYM cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -26155000.00
CHYM cash_flow (quarterly, 2025-03-31) — Changes In Cash: -19176000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Common Stock: 2000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -1908104000.00
CHYM cash_flow (quarterly, 2025-03-31) — Common Stock Payments: 0.00
CHYM income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 60418000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 100033000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Current Assets: 1265830000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 14274000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 14274000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 333545000.00
CHYM cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 7258000.00
CHYM income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 3807000.00
CHYM cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 7258000.00
CHYM income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 3807000.00
CHYM income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 364421538.00
CHYM income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.00
CHYM income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 0.00
CHYM income_statement (quarterly, 2025-03-31) — EBIT: 9137000.00
CHYM income_statement (quarterly, 2025-03-31) — EBITDA: 16395000.00
CHYM cash_flow (quarterly, 2025-03-31) — End Cash Position: 330824000.00
CHYM cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -126000.00
CHYM cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -30542000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 294000.00
CHYM income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 47173000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Gross PPE: 190156000.00
CHYM income_statement (quarterly, 2025-03-31) — Gross Profit: 458326000.00
CHYM cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 43000.00
CHYM cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 165000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Invested Capital: -1908104000.00
CHYM cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 6701000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Leases: 62966000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Loans Receivable: 100106000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 77426000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 77426000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 80091000.00
CHYM cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
CHYM income_statement (quarterly, 2025-03-31) — Net Income: 12939000.00
CHYM income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 0.00
CHYM income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 12939000.00
CHYM income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 12939000.00
CHYM income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 12939000.00
CHYM cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 12939000.00
CHYM income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 12939000.00
CHYM cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 33699000.00
CHYM cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -843000.00
CHYM cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -22207000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Net PPE: 137797000.00
CHYM cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -1593000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 982017000.00
CHYM income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 16395000.00
CHYM income_statement (quarterly, 2025-03-31) — Normalized Income: 12939000.00
CHYM cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -25751000.00
CHYM income_statement (quarterly, 2025-03-31) — Operating Income: 9137000.00
CHYM income_statement (quarterly, 2025-03-31) — Operating Revenue: 518744000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 364421538.00
CHYM balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 79204000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 167813000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 294000.00
CHYM income_statement (quarterly, 2025-03-31) — Other Gand A: 47173000.00
CHYM income_statement (quarterly, 2025-03-31) — Other Income Expense: 5354000.00
CHYM cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 30726000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 32372000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 43011000.00
CHYM income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 5354000.00
CHYM income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 187754000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Other Properties: 47099000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 336467000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Payables: 37614000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 137647000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 13811000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 2890121000.00
CHYM income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 12939000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 2890121000.00
CHYM income_statement (quarterly, 2025-03-31) — Pretax Income: 14491000.00
CHYM cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 717000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
CHYM cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 41520000.00
CHYM cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -38502000.00
CHYM cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -1593000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Receivables: 341763000.00
CHYM income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 56967000.00
CHYM income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 7258000.00
CHYM cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
CHYM income_statement (quarterly, 2025-03-31) — Research And Development: 77882000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 190236000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -2351229000.00
CHYM cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 72201000.00
CHYM income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 132573000.00
CHYM income_statement (quarterly, 2025-03-31) — Selling General And Administration: 179746000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Share Issued: 364421538.00
CHYM cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 8696000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 982017000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -1908104000.00
CHYM income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CHYM income_statement (quarterly, 2025-03-31) — Tax Provision: 1552000.00
CHYM income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.11
CHYM balance_sheet (quarterly, 2025-03-31) — Total Assets: 1435999000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 982017000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Total Debt: 91700000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 982017000.00
CHYM income_statement (quarterly, 2025-03-31) — Total Expenses: 509607000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 453982000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 170169000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 120437000.00
CHYM income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 9137000.00
CHYM balance_sheet (quarterly, 2025-03-31) — Working Capital: 932285000.00
CHYM income_statement (quarterly, 2025-06-30) — +Operating Expense: 1391667000.00
CHYM income_statement (quarterly, 2025-06-30) — +Total Revenue: 528149000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 51800000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 229594000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -59358000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 4702788000.00
CHYM cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -738000.00
CHYM cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 0.00
CHYM income_statement (quarterly, 2025-06-30) — Basic Average Shares: 126620499.00
CHYM income_statement (quarterly, 2025-06-30) — Basic EPS: -7.29
CHYM cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 330824000.00
CHYM cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -5229000.00
CHYM cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -3191000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 87864000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Capital Stock: 31000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 868284000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1093347000.00
CHYM cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 450056000.00
CHYM cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 72425000.00
CHYM cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 28494000.00
CHYM cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 14186000.00
CHYM cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -19337000.00
CHYM cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -4357000.00
CHYM cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -35411000.00
CHYM cash_flow (quarterly, 2025-06-30) — Change In Payable: 14186000.00
CHYM cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -5151000.00
CHYM cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 7248000.00
CHYM cash_flow (quarterly, 2025-06-30) — Change In Receivables: 11813000.00
CHYM cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -25858000.00
CHYM cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 11813000.00
CHYM cash_flow (quarterly, 2025-06-30) — Changes In Cash: 550975000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Common Stock: 31000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1428098000.00
CHYM cash_flow (quarterly, 2025-06-30) — Common Stock Payments: 0.00
CHYM income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 67120000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 91930000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Current Assets: 1736079000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 13099000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 13099000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 359698000.00
CHYM cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 7411000.00
CHYM income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 3896000.00
CHYM cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 7411000.00
CHYM income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 3896000.00
CHYM income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 126620499.00
CHYM income_statement (quarterly, 2025-06-30) — Diluted EPS: -7.29
CHYM income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -923376000.00
CHYM income_statement (quarterly, 2025-06-30) — EBIT: -930638000.00
CHYM income_statement (quarterly, 2025-06-30) — EBITDA: -923227000.00
CHYM cash_flow (quarterly, 2025-06-30) — End Cash Position: 881799000.00
CHYM cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 450056000.00
CHYM cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 23265000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -116000.00
CHYM income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 279667000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Goodwill: 27492000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 27492000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Gross PPE: 194034000.00
CHYM income_statement (quarterly, 2025-06-30) — Gross Profit: 461029000.00
CHYM cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 1028000.00
CHYM cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: -25000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Invested Capital: 1428098000.00
CHYM cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 72425000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Leases: 63754000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Loans Receivable: 114120000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 74765000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 74765000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 84705000.00
CHYM cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 772556000.00
CHYM income_statement (quarterly, 2025-06-30) — Net Income: -923376000.00
CHYM income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -923376000.00
CHYM income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -923376000.00
CHYM income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -923376000.00
CHYM income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -923376000.00
CHYM cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -923376000.00
CHYM income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -923376000.00
CHYM cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 111965000.00
CHYM cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -322910000.00
CHYM cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -34311000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Net PPE: 134676000.00
CHYM cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -2038000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 1400606000.00
CHYM income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -923227000.00
CHYM income_statement (quarterly, 2025-06-30) — Normalized Income: -923376000.00
CHYM cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 28494000.00
CHYM income_statement (quarterly, 2025-06-30) — Operating Income: -930638000.00
CHYM income_statement (quarterly, 2025-06-30) — Operating Revenue: 528149000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 370776813.00
CHYM balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 72520000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 171601000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -116000.00
CHYM income_statement (quarterly, 2025-06-30) — Other Gand A: 279667000.00
CHYM income_statement (quarterly, 2025-06-30) — Other Income Expense: 6215000.00
CHYM cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 27287000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 4227000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 39913000.00
CHYM income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 6215000.00
CHYM income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 301344000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Other Properties: 45575000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 225063000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Payables: 51800000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 143730000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 31268000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CHYM income_statement (quarterly, 2025-06-30) — Pretax Income: -924423000.00
CHYM cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 410000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
CHYM cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 33621000.00
CHYM cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -195548000.00
CHYM cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -2038000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Receivables: 343714000.00
CHYM income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 63605000.00
CHYM income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 7411000.00
CHYM cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: 0.00
CHYM income_statement (quarterly, 2025-06-30) — Research And Development: 621754000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 226498000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -3274605000.00
CHYM cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 307513000.00
CHYM income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 185006000.00
CHYM income_statement (quarterly, 2025-06-30) — Selling General And Administration: 464673000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Share Issued: 370776813.00
CHYM cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 910147000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1428098000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 1400606000.00
CHYM income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CHYM income_statement (quarterly, 2025-06-30) — Tax Provision: -1047000.00
CHYM income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
CHYM balance_sheet (quarterly, 2025-06-30) — Total Assets: 1902474000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1428098000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Total Debt: 87864000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1428098000.00
CHYM income_statement (quarterly, 2025-06-30) — Total Expenses: 1458787000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 474376000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 166395000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 114678000.00
CHYM income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -930638000.00
CHYM balance_sheet (quarterly, 2025-06-30) — Working Capital: 1376381000.00
CHYM income_statement (quarterly, 2025-09-30) — +Operating Expense: 538828000.00
CHYM income_statement (quarterly, 2025-09-30) — +Total Revenue: 543519000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 40026000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 237652000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -66453000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 4772649000.00
CHYM cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -1645000.00
CHYM cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
CHYM income_statement (quarterly, 2025-09-30) — Basic Average Shares: 371829972.00
CHYM income_statement (quarterly, 2025-09-30) — Basic EPS: -0.15
CHYM cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 881799000.00
CHYM cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -3714000.00
CHYM cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -1657000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 137763000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Capital Stock: 31000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 445026000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1078764000.00
CHYM cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -16972000.00
CHYM cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -423609000.00
CHYM cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 17484000.00
CHYM cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -11774000.00
CHYM cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -4673000.00
CHYM cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -6710000.00
CHYM cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -15972000.00
CHYM cash_flow (quarterly, 2025-09-30) — Change In Payable: -11774000.00
CHYM cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -16447000.00
CHYM cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -6349000.00
CHYM cash_flow (quarterly, 2025-09-30) — Change In Receivables: -8280000.00
CHYM cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -53758000.00
CHYM cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -8280000.00
CHYM cash_flow (quarterly, 2025-09-30) — Changes In Cash: -423097000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Common Stock: 31000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 1443274000.00
CHYM cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: -1317000.00
CHYM cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
CHYM income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 69401000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 89315000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Current Assets: 1758897000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 11922000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 11922000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 355915000.00
CHYM cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 7514000.00
CHYM income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 3992000.00
CHYM cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 7514000.00
CHYM income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 3992000.00
CHYM income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 371829972.00
CHYM income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.15
CHYM income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -54722000.00
CHYM income_statement (quarterly, 2025-09-30) — EBIT: -64710000.00
CHYM income_statement (quarterly, 2025-09-30) — EBITDA: -57196000.00
CHYM cash_flow (quarterly, 2025-09-30) — End Cash Position: 458702000.00
CHYM cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -16972000.00
CHYM cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 13770000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -79000.00
CHYM income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 76575000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Goodwill: 27492000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 27492000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Gross PPE: 238585000.00
CHYM income_statement (quarterly, 2025-09-30) — Gross Profit: 474118000.00
CHYM cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 68000.00
CHYM cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 269000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1443274000.00
CHYM cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -423609000.00
CHYM cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: -1317000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Leases: 65648000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Loans Receivable: 108996000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 125841000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 125841000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 87285000.00
CHYM cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
CHYM cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -1317000.00
CHYM income_statement (quarterly, 2025-09-30) — Net Income: -54722000.00
CHYM income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -54722000.00
CHYM income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -54722000.00
CHYM income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -54722000.00
CHYM income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -54722000.00
CHYM cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -54722000.00
CHYM income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -54722000.00
CHYM cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -407233000.00
CHYM cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -25453000.00
CHYM cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -12662000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Net PPE: 172132000.00
CHYM cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -2057000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 1415782000.00
CHYM income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -57196000.00
CHYM income_statement (quarterly, 2025-09-30) — Normalized Income: -54722000.00
CHYM cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 17484000.00
CHYM income_statement (quarterly, 2025-09-30) — Operating Income: -64710000.00
CHYM income_statement (quarterly, 2025-09-30) — Operating Revenue: 543519000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 374417665.00
CHYM balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 90854000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 171974000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -79000.00
CHYM income_statement (quarterly, 2025-09-30) — Other Gand A: 76575000.00
CHYM income_statement (quarterly, 2025-09-30) — Other Income Expense: 10268000.00
CHYM cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 167000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 3790000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 37281000.00
CHYM income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 10268000.00
CHYM income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 180711000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Other Properties: 85652000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 633738000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Payables: 40026000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 129341000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 42678000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CHYM income_statement (quarterly, 2025-09-30) — Pretax Income: -54442000.00
CHYM cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 9798000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
CHYM cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 35173000.00
CHYM cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
CHYM cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -431233000.00
CHYM cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -2057000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Receivables: 346648000.00
CHYM income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 65879000.00
CHYM income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 7514000.00
CHYM cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
CHYM income_statement (quarterly, 2025-09-30) — Research And Development: 123942000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 242631000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -3329327000.00
CHYM cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 24000000.00
CHYM income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 153608000.00
CHYM income_statement (quarterly, 2025-09-30) — Selling General And Administration: 230183000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Share Issued: 374417665.00
CHYM cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 84755000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 1443274000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 1415782000.00
CHYM income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CHYM income_statement (quarterly, 2025-09-30) — Tax Provision: 280000.00
CHYM income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
CHYM balance_sheet (quarterly, 2025-09-30) — Total Assets: 1962311000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1443274000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Total Debt: 137763000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1443274000.00
CHYM income_statement (quarterly, 2025-09-30) — Total Expenses: 608229000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 519037000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 203414000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 163122000.00
CHYM income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -64710000.00
CHYM balance_sheet (quarterly, 2025-09-30) — Working Capital: 1402982000.00
CHYM income_statement (annual, 2025-12-31) — +Operating Expense: 2963702000.00
CHYM income_statement (quarterly, 2025-12-31) — +Operating Expense: 584018000.00
CHYM income_statement (annual, 2025-12-31) — +Total Revenue: 2186770000.00
CHYM income_statement (quarterly, 2025-12-31) — +Total Revenue: 596358000.00
CHYM balance_sheet (annual, 2025-12-31) — Accounts Payable: 38680000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 38680000.00
CHYM balance_sheet (annual, 2025-12-31) — Accounts Receivable: 257884000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 257884000.00
CHYM balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -73831000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -73831000.00
CHYM balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 4775607000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 4775607000.00
CHYM cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
CHYM cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
CHYM income_statement (annual, 2025-12-31) — Basic Average Shares: 236270347.00
CHYM income_statement (quarterly, 2025-12-31) — Basic Average Shares: 375865879.00
CHYM income_statement (annual, 2025-12-31) — Basic EPS: -4.27
CHYM income_statement (quarterly, 2025-12-31) — Basic EPS: -0.12
CHYM cash_flow (annual, 2025-12-31) — Beginning Cash Position: 350000000.00
CHYM cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 458702000.00
CHYM cash_flow (annual, 2025-12-31) — Capital Expenditure: -28720000.00
CHYM cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -14986000.00
CHYM cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -8833000.00
CHYM cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -787000.00
CHYM balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 134665000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 134665000.00
CHYM balance_sheet (annual, 2025-12-31) — Capital Stock: 31000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Capital Stock: 31000.00
CHYM balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 466252000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 466252000.00
CHYM balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1054080000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1054080000.00
CHYM cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 367668000.00
CHYM cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -65290000.00
CHYM cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -289688000.00
CHYM cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 54795000.00
CHYM cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 52780000.00
CHYM cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 32553000.00
CHYM cash_flow (annual, 2025-12-31) — Change In Account Payable: 2834000.00
CHYM cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -1346000.00
CHYM cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -77432000.00
CHYM cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 20532000.00
CHYM cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -23657000.00
CHYM cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 9803000.00
CHYM cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -69481000.00
CHYM cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -22249000.00
CHYM cash_flow (annual, 2025-12-31) — Change In Payable: 2834000.00
CHYM cash_flow (quarterly, 2025-12-31) — Change In Payable: -1346000.00
CHYM cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -74598000.00
CHYM cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 19186000.00
CHYM cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -23624000.00
CHYM cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -15843000.00
CHYM cash_flow (annual, 2025-12-31) — Change In Receivables: -42957000.00
CHYM cash_flow (quarterly, 2025-12-31) — Change In Receivables: -20335000.00
CHYM cash_flow (annual, 2025-12-31) — Change In Working Capital: -234317000.00
CHYM cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -29438000.00
CHYM cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -42957000.00
CHYM cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -20335000.00
CHYM cash_flow (annual, 2025-12-31) — Changes In Cash: 130760000.00
CHYM cash_flow (quarterly, 2025-12-31) — Changes In Cash: 22058000.00
CHYM balance_sheet (annual, 2025-12-31) — Common Stock: 31000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Common Stock: 31000.00
CHYM balance_sheet (annual, 2025-12-31) — Common Stock Equity: 1401706000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 1401706000.00
CHYM cash_flow (annual, 2025-12-31) — Common Stock Issuance: 770588000.00
CHYM cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: -651000.00
CHYM cash_flow (annual, 2025-12-31) — Common Stock Payments: -77538000.00
CHYM cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -77538000.00
CHYM income_statement (annual, 2025-12-31) — Cost Of Revenue: 263047000.00
CHYM income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 66108000.00
CHYM balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 91934000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 91934000.00
CHYM balance_sheet (annual, 2025-12-31) — Current Assets: 1756010000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Current Assets: 1756010000.00
CHYM balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 11381000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 11381000.00
CHYM balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 11381000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 11381000.00
CHYM balance_sheet (annual, 2025-12-31) — Current Liabilities: 387924000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 387924000.00
CHYM cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 30000000.00
CHYM cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 7817000.00
CHYM income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 15979000.00
CHYM income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 4284000.00
CHYM cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 30000000.00
CHYM cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 7817000.00
CHYM income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 15979000.00
CHYM income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 4284000.00
CHYM income_statement (annual, 2025-12-31) — Diluted Average Shares: 236270347.00
CHYM income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 375865879.00
CHYM income_statement (annual, 2025-12-31) — Diluted EPS: -4.27
CHYM income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.12
CHYM income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -1009936000.00
CHYM income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -44777000.00
CHYM income_statement (annual, 2025-12-31) — EBIT: -1039979000.00
CHYM income_statement (quarterly, 2025-12-31) — EBIT: -53768000.00
CHYM income_statement (annual, 2025-12-31) — EBITDA: -1009979000.00
CHYM income_statement (quarterly, 2025-12-31) — EBITDA: -45951000.00
CHYM cash_flow (annual, 2025-12-31) — End Cash Position: 480760000.00
CHYM cash_flow (quarterly, 2025-12-31) — End Cash Position: 480760000.00
CHYM cash_flow (annual, 2025-12-31) — Financing Cash Flow: 367668000.00
CHYM cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -65290000.00
CHYM cash_flow (annual, 2025-12-31) — Free Cash Flow: 24060000.00
CHYM cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 17567000.00
CHYM balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 172000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 172000.00
CHYM income_statement (annual, 2025-12-31) — General And Administrative Expense: 512113000.00
CHYM income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 108698000.00
CHYM balance_sheet (annual, 2025-12-31) — Gross PPE: 251580000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Gross PPE: 251580000.00
CHYM income_statement (annual, 2025-12-31) — Gross Profit: 1923723000.00
CHYM income_statement (quarterly, 2025-12-31) — Gross Profit: 530250000.00
CHYM cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 1126000.00
CHYM cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: -13000.00
CHYM cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 330000.00
CHYM cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: -79000.00
CHYM balance_sheet (annual, 2025-12-31) — Invested Capital: 1401706000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Invested Capital: 1401706000.00
CHYM cash_flow (annual, 2025-12-31) — Investing Cash Flow: -289688000.00
CHYM cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 54795000.00
CHYM cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 770588000.00
CHYM cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: -651000.00
CHYM balance_sheet (annual, 2025-12-31) — Leases: 79429000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Leases: 79429000.00
CHYM balance_sheet (annual, 2025-12-31) — Loans Receivable: 71581000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Loans Receivable: 71581000.00
CHYM balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 123284000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 123284000.00
CHYM balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 123284000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 123284000.00
CHYM balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 88722000.00
CHYM balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 88722000.00
CHYM cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 0.00
CHYM cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00